glp-1 agonists vision loss blindness Recent studies have begun to explore a possible link between receptor (like semaglutide) and a rare but serious cause of sudden known as non-arteritic anterior ischemic Popular GLP-1 Weight Loss Drugs
Description
Approximately 40-60% of private Canadian plans cover obesity medications with prior authorization

The researchers of that study called for urgent clarification of drug- and patient-related risk factors, an understanding that has become more important as GLP-1 receptor agonist use continues to rise across the United States, especially for weight management

And liability does not stop with the prescribing physician

Diabetes Care 46 , 249251 (2023)

48,49 Heart Rate Increase GLP-1RAs are known to cause a modest, dose-dependent increase in resting heart rate
Additionally, we were unable to evaluate the exact reasons for drug prescriptions, medication switches, or adherence